Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONACO: MON002 for post-COVID pulmonary fibrosis
NCT04805086Phase 2Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2021
- Primary completion
- Jun 2022
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MON002 in pulmonary fibrosis (PF), sponsored by Guy's and St Thomas' NHS Foundation Trust. Status: unknown.
02
Drugs
MON002
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT04805086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04805086.